Clinical Trial Update: BAROSTIM NEO Hypertension Pivotal Trial [NA]

View source ↗

Summary

The pivotal BAROSTIM NEO hypertension trial has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• BAROSTIM NEO

Snippet

Sponsor: CVRx, Inc. | Conditions: Uncontrolled Hypertension | NA | Status: SUSPENDED